Evidence map›Paper›PMID 29168155›Full record

ArticleProbiotics and antimicrobial proteins2018

In Silico and Experimental Data Claiming Safety Aspects and Beneficial Attributes of the Bacteriocinogenic Strain Enterococcus faecalis B3A-B3B.

Alaa Al Seraih, Yanath Belguesmia, Benoit Cudennec, John Baah, Djamel Drider

Abstract read
PubMed Publisher
In one paragraph

Article in Probiotics and antimicrobial proteins, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Protective Effects of NovelMicroorganisms · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Probiotic Potential and Safety Evaluation ofFrontiers in microbiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alaa Al SeraihUniversité de Lille, INRA, ISA, Université d'Artois, Université du Littoral-Côte d'Opale, EA 7394 Institut Charles Viollette, 59000, Lille, France.
Yanath BelguesmiaUniversité de Lille, INRA, ISA, Université d'Artois, Université du Littoral-Côte d'Opale, EA 7394 Institut Charles Viollette, 59000, Lille, France. yanath.belguesmia@polytech-lille.fr.
Benoit CudennecUniversité de Lille, INRA, ISA, Université d'Artois, Université du Littoral-Côte d'Opale, EA 7394 Institut Charles Viollette, 59000, Lille, France.
John BaahBest Environmental Technologies Inc, 9610-39 Avenue NW, Edmonton, Alberta, T6E 5T9, Canada.
Djamel DriderUniversité de Lille, INRA, ISA, Université d'Artois, Université du Littoral-Côte d'Opale, EA 7394 Institut Charles Viollette, 59000, Lille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed at comparing the genome of Enterococcus faecalis B3A-B3B, a bacteriocinogenic strain recently isolated from a healthy Iraqi infant to those of Enterococci of clinical and beneficial grades. The putative genes gelE, cpd, efaAfm, ccf, agg, and cob coding for virulence factors were detected in B3A-B3B strain, which meanwhile resulted to be non-cytotoxic, non-hemolytic, devoid of inflammatory effects, and sensitive to most of the antibiotics tested except for clindamycin and trimethoprim, which resistance is usually ascribed to intrinsic nature. B3A-B3B strain was remarkable for its hydrophobicity, auto-aggregation, adhesion to human Caco-2 cells, and survival in simulated gastrointestinal conditions, and cholesterol assimilation fulfilling therefore key beneficial attributes.

Indexed as

Anti-Bacterial AgentsBacterial ProteinsBacteriocinsCaco-2 CellsComputer SimulationDrug Resistance, BacterialEnterococcus faecalisGastrointestinal TractHumansMicrobial Sensitivity TestsMicrobial ViabilityVirulence FactorsAnti-Bacterial AgentsBacterial ProteinsBacteriocinsVirulence FactorsBacteriocinBeneficial traitsEnterococcus faecalisIn silico analysisLactic acid bacteria

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.